| Income Statement | 2025-10-31 | |||
|---|---|---|---|---|
| Research and development | 94,480 | |||
| General and administrative | 28,685 | |||
| Total operating expenses | 123,165 | |||
| Loss from operations | -123,165 | |||
| Interest income | 9,426 | |||
| Interest expense | 2,994 | |||
| Gain on extinguishment of debt | 0 | |||
| Other expenses (income), net | -569 | |||
| Total other income, net | 5,863 | |||
| Net loss before income taxes | -117,302 | |||
| Provision for (recovery of) income taxes | 0 | |||
| Net loss | -117,302 | |||
| Unrealized (gain) loss on available-for-sale investments | 531 | |||
| Total comprehensive loss | -116,771 | |||
| Earnings per share, basic, total | 2.29 | |||
| Earnings per share, diluted, total | 2.29 | |||
| Weighted-average number of common shares used in net loss per share, basic | 51,119,479 | |||
| Weighted-average number of common shares used in net loss per share, diluted | 51,119,479 | |||
enGene Holdings Inc. (ENGNW)
enGene Holdings Inc. (ENGNW)